Skip to main content
If you continue browsing this website, you agree to our policies:
  • Politique de confidentialité
Continue
x
eCampus
  • Home
  • Outils
    Portfolio Mahara Wooclap
  • Tutoriels
    bientôt disponible !
  • More
English ‎(en)‎
English ‎(en)‎ Español - Internacional ‎(es)‎ Français ‎(fr)‎
You are currently using guest access
Log in
eCampus
Home Outils Collapse Expand
Portfolio Mahara Wooclap
Tutoriels Collapse Expand
bientôt disponible !
Expand all Collapse all
  1. Dashboard
  2. M1 D2HP 24-25
  3. TU 08: Biotechnology (S1)
  4. Quality Control of therapeutic proteins

Quality Control of therapeutic proteins

Completion requirements
    • acidic and basic variants analysis of monoclonal antibodies by IEX-HPLC acidic and basic variants analysis of monoclonal antibodies by IEX-HPLC
      • Agilent publication 2.pdf Agilent publication 2.pdf
      • Bai et al., 2000.pdf Bai et al., 2000.pdf
      • fekete 2015.pdf fekete 2015.pdf
      • SUPPOR~1.PPT SUPPOR~1.PPT
      • zhang2013.pdf zhang2013.pdf
    • Capillary Gel electrophoresis for identity and purity control of therapeutic proteins Capillary Gel electrophoresis for identity and purity control of therapeutic proteins
      • Bhimwal et al., 2022.pdf Bhimwal et al., 2022.pdf
      • ce-SDS-analysis-therapeutic-proteins.pdf ce-SDS-analysis-therapeutic-proteins.pdf
      • Hajba et al., 2023 from page 1 to 5.pdf Hajba et al., 2023 from page 1 to 5.pdf
      • IntroductiontoCapillaryElectrophoresisVol-I page 21.pdf IntroductiontoCapillaryElectrophoresisVol-I page 21.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- CGE-2024.pptx
    • control of secondary Structure of therapeutic proteins control of secondary Structure of therapeutic proteins
      • AN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdf AN52985-protein-secondary-structure-elucidation-FTIR-spectroscopy.pdf
      • cerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdf cerasolini 2014-Temperature denaturation and aggregation of a multi-domain IGG by biophysical methods.pdf
      • Siligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdf Siligardi-Hussain2015_Protocol_CDSpectroscopyAnEssentialToolF.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- Circular dichroism 2024.pptx
    • Detection of chemical-degradation variants of therapeutic proteins by RP-HPLC Detection of chemical-degradation variants of therapeutic proteins by RP-HPLC
      • AmershamRPCManual RP HPLC Theory.pdf AmershamRPCManual RP HPLC Theory.pdf
      • Fagan 2024.pdf Fagan 2024.pdf
      • kim 2015.pdf kim 2015.pdf
      • lorbetskie 2022.pdf lorbetskie 2022.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptx SUPPORTING SLIDES - ORAL PRESENTATION- RP-HPLC- 2024 (1).pptx
    • N-glycan mapping of therapeutic glycoproteins by HILIC-HPLC N-glycan mapping of therapeutic glycoproteins by HILIC-HPLC
      • kmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdf kmab-glycan analysis of therapeutic proteins- Zhang L 2016.pdf
      • Planinc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdf Planinc 2016-ACA-Glycan characterization of biopharmaceuticals-Updates and perspectives.pdf
      • SUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptx SUPPORTING SLIDES FOR PREPARING THE ORAL PRESENTATION- Glycan profiling 2024.pptx
    • Peptide mapping of therapeutic proteins by RP-HLC as an identity control Peptide mapping of therapeutic proteins by RP-HLC as an identity control
      • bobaly et al., 2017.pdf bobaly et al., 2017.pdf
      • Bongers et al., 2000.pdf Bongers et al., 2000.pdf
      • focus on peptide mapping , analytical condition and mechanism.pdf focus on peptide mapping , analytical condition and mechanism.pdf
      • Garnik et al., 1988.pdf Garnik et al., 1988.pdf
      • SUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptx SUPPORTING SLIDES - ORAL PRESENTATION- peptide mapping 2024.pptx
    • Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC) Purity control of therapeutic proteins by size exclusion chromatography (SEC-HPLC)
      • berkowitz2020.pdf berkowitz2020.pdf
      • Biopharmaceuticals - SEC.pdf Biopharmaceuticals - SEC.pdf
      • Fekete 2014.pdf Fekete 2014.pdf
      • hall2018.pdf hall2018.pdf
      • SUPPOR~1.PPT SUPPOR~1.PPT
    • SDS-PAGE for purity and identity controls of therapeutic proteins SDS-PAGE for purity and identity controls of therapeutic proteins
      • reichel et al., 2013.pdf reichel et al., 2013.pdf
      • roy kumar 2014.pdf roy kumar 2014.pdf
      • SILVAE~1.PDF SILVAE~1.PDF
      • SUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptx SUPPORTING SLIDES - ORAL PRESENTATION- SDS 2024 (1).pptx
    • QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf QC biopharmaceuticals -M1-2024-MT3-17 oct 2024.pdf
    • separation methods -brief summary.pdf separation methods -brief summary.pdf
◄ Examples of exam
documents ►
You are currently using guest access (Log in)
Policies
Get the mobile app
Powered by Moodle

eCampus

Université Paris-Saclay 7
  • UPSaclay
  • UEVE
  • UVSQ
  • Centrale Supélec
  • École Normale Supérieure
  • Institut d'Optique
  • AgroParisTech
Institut Polytechnique de Paris 3
  • ENSTA
  • Télécom Paris

European University Alliance for Global Health (EUGLOH)
  •  


Nouveautés